onc Videos

Videos

Ruben A. Mesa, MD, FACP, Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Videos

Novel Advances in the Treatment of Patients With Myelofibrosis

11/07/2023

Featuring Ruben A. Mesa, MD, FACP

Featuring Ruben A. Mesa, MD, FACP ...

At the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Ruben A. Mesa, MD, FACP, discusses the latest updates in myelofibrosis treatment.

At the 2023 Lymphoma, Leukemia &...

11/07/2023

Lymphoma, Leukemia & Myeloma Network

Filippo Pietrantonio, MD, National Cancer Center Milan

Videos

Sotorasib Plus Panitumumab Improved PFS Among Patients With Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer

11/07/2023

Featuring Filippo Pietrantonio, MD

Featuring Filippo Pietrantonio, MD ...

Primary results from the phase 3 CodeBreaK 300 trial found that sotorasib plus panitumumab improved progression-free survival among patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer, compared with the standard of...

Primary results from the phase 3...

11/07/2023

Oncology

Videos

Selecting CAR T-Cell Therapy for Older Patients With Diffuse Large B-Cell Lymphoma

11/07/2023

Featuring Jason Westin, MD

At the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, New York, Jason Westin, MD, participated in a debate regarding choice of CAR T-cell therapy versus novel therapy for older adults with diffuse large B-cell lymphoma.

At the 2023 Lymphoma, Leukemia &...

11/07/2023

Lymphoma, Leukemia & Myeloma Network

Conference Coverage

Tissue and Liquid Biopsies Effective for Detecting MET Exon 14 Skipping Mutations in NSCLC

11/06/2023

Featuring Christian Rolfo, MD, PhD

Featuring Christian Rolfo, MD, PhD ...

Christian Rolfo, MD, PhD, Icahn School of Medicine, Mount Sinai Medical Center, New York, New York, discusses results from the phase 2 VISION trial.

Christian Rolfo, MD, PhD, Icahn...

11/06/2023

Oncology

Videos

Diagnosis and Risk Stratification of Mantle Cell Lymphoma: Part 1

11/03/2023

Featuring Kami Maddocks, MD, Jia Ruan, MD, PhD, and Krish Patel, MD

Featuring Kami Maddocks, MD, Jia Ruan...

In the first part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD, on the diagnostics and risk stratification of mantle cell lymphoma.

In the first part of an expert...

11/03/2023

Oncology

Videos

Long-Term Updates on Chemotherapy-Free Lenalidomide Plus Rituximab Treatment for MCL

11/03/2023

Featuring Jia Ruan, MD, PhD

Jia Ruan, MD, PhD, shares 9-year follow-up findings from a phase 2 trial on the outcomes of chemotherapy-free lenalidomide plus rituximab combination therapy among patients with mantle cell lymphoma.

Jia Ruan, MD, PhD, shares 9-year...

11/03/2023

Oncology

Andrea Necchi, MD, San Raffaele Hospital

Videos

Intravesical Gemcitabine Delivery System, TAR-200, Shows Promise Among Patients With BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer

11/03/2023

Featuring Andrea Necchi, MD

Andrea Necchi, MD, describes the results from cohort 2 of the SunRISe-1 trial, evaluating TAR-200 monotherapy among patients with high-risk, BCG-unresponsive non–muscle-invasive bladder cancer.

Andrea Necchi, MD, describes the...

11/03/2023

Oncology

Videos

Addition of Induction Chemotherapy to Standard-of-Care Chemoradiation Improves Survival Outcomes in Locally Advanced Cervical Cancer

11/02/2023

Featuring Mary McCormack, MD

Mary McCormack, MD discusses results from the phase 3 GCIG INTERLACE study evaluating the addition of induction chemotherapy to standard-of-care chemoradiation among patients with advanced cervical cancer.

Mary McCormack, MD discusses...

11/02/2023

Oncology

Gareth Morgan, MD, NYU Langone Medical Center

Videos

Role of Tumor Complexity and Microenvironment in the Development of Multiple Myeloma

11/02/2023

Featuring Gareth Morgan, MD

During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Gareth Morgan, MD, examines the role of tumor complexity and microenvironment in the development of multiple myeloma.

During the 2023 Lymphoma,...

11/02/2023

Lymphoma, Leukemia & Myeloma Network

Shahneen Sandhu, MBBS, Peter MacCallum Cancer Centre

Videos

Prevalence of DNA Repair Defects Among Patients With Metastatic Prostate Cancer

11/02/2023

Featuring Shahneen Sandhu, MBBS

Featuring Shahneen Sandhu, MBBS ...

In a prospective observational study, approximately 14% of patients with metastatic prostate cancer harbored at least 1 HRR gene alteration, most commonly BRCA.

In a prospective observational...

11/02/2023

Oncology

Recent News

News

Osimertinib Lacks Activity in Neoadjuvant Setting for Early-Stage Non-Small Cell Lung Cancer With EGFR Mutation

08/08/2024

Stephanie Holland ;

Results from a phase 2 study demonstrated that neoadjuvant osimertinib did not improve the major pathological response rate among patients with early-stage non-small cell lung cancer harboring an EGFR mutation.

Results from a phase 2 study...

08/08/2024

Oncology

FDA Approval

FDA Approves Denileukin Diftitox for Patients With R/R Cutaneous T-Cell Lymphoma

08/08/2024

Amber Denham ;

The US Food and Drug Administration approved novel immunotherapy denileukin diftitox-cxdl for the treatment of patients with relapsed/refractory cutaneous T-cell lymphoma after at least 1 prior systemic therapy.

The US Food and Drug...

08/08/2024

Oncology

News

Tailored Dose-Dense Chemotherapy Improved Survival Outcomes Among Patients With High-Risk Early Breast Cancer

08/07/2024

Stephanie Holland ;

According to results from the phase 3 PANTHER trial, tailored and dose-dense chemotherapy in the adjuvant setting improved survival outcomes compared to standard chemotherapy among patients with high-risk early breast cancer.

According to results from the...

08/07/2024

Oncology

News

Frontline Treatment Management for Patients With FL Reduces Risk of High-Grade Transformation to DLBCL

08/07/2024

Amber Denham ;

A recent study demonstrated that frontline treatment management reduced the risk of high-grade transformation to diffuse large B-cell lymphoma among patients with follicular lymphoma, but not among patients with marginal zone lymphoma.

A recent study demonstrated that...

08/07/2024

Oncology

News

Optimal Sotorasib Dose for Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

08/07/2024

Stephanie Holland ;

Results from a phase 2 study found that 960 mg of sotorasib is preferable to 240 mg among patients with previously treated KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer.

Results from a phase 2 study...

08/07/2024

Oncology

FDA Approval

FDA Approves Vorasidenib for Patients With IDH1/IDH2-Mutated Grade 2 Astrocytoma or Oligodendroglioma

08/06/2024

Stephanie Holland ;

Based on results from the INDIGO trial, the FDA has approved vorasidenib for adult and pediatric patients 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation following surgery.

Based on results from the INDIGO...

08/06/2024

Oncology

FDA Approval

FDA Approves Afamitresgene Autoleucel for Certain Unresectable or Metastatic Synovial Sarcoma

08/02/2024

Allison Casey ;

On August 2, 2024, the US Food and Drug Administration (FDA) granted accelerated approval to afamitresgene autoleucel for the treatment of adult patients with certain unresectable or metastatic synovial sarcomas who had received prior...

On August 2, 2024, the US Food...

08/02/2024

Oncology

FDA Approval

FDA Approves Dostarlimab Plus Chemotherapy for Patients With Primary Advanced or Recurrent Endometrial Cancer

08/01/2024

Allison Casey ;

The FDA approved dostarlimab plus carboplatin and paclitaxel, followed by single-agent dostarlimab for patients with primary advanced or recurrent endometrial cancer.

The FDA approved dostarlimab...

08/01/2024

Oncology

News

Iadademstat and Azacitidine Combination Therapy Demonstrates Manageable Safety, Promising Efficacy for Patients With Newly Diagnosed AML

08/01/2024

Amber Denham ;

The first-line combination of iadademstat and azacitidine demonstrates a manageable safety profile and promising results among patients with acute myeloid leukemia, according to phase 2 results from the ALICE trial.

The first-line combination of...

08/01/2024

Oncology

News

Effect of Food on Selumetinib Dosing for Adolescent Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

08/01/2024

Allison Casey ;

In the phase 1 trial, the addition of a low-fat meal with doses of selumetinib did not significantly impact selumetinib exposure or gastrointestinal toxicities among adolescent patients with neurofibromatosis type 1 with plexiform...

In the phase 1 trial, the...

08/01/2024

Oncology